Literature DB >> 2545910

Mapping of functional regions of murine retrovirus long terminal repeat enhancers: enhancer domains interact and are not independent in their contributions to enhancer activity.

T Hollon1, F K Yoshimura.   

Abstract

We have used deletion and recombinant long terminal repeat (LTR) mutants to examine enhancer activity differences between LTRs of the nonpathogenic Akv and the thymus lymphomagenic MCF13 murine retroviruses. Deletion mutant analysis revealed that major control regions for MCF13 and Akv LTR enhancer activity were similar but not identical. For both LTRs, major control regions were distinctly different in a murine T-cell and a fibroblast cell line. Recombinant enhancer analysis showed that LTRs could be divided into three regions capable of altering the level of enhancer activity through cooperative or antagonistic interaction. The contribution of each region to enhancer activity was dependent on its context with respect to the other regions. LTR enhancer function in different cell types appears to be the result of the interaction of enhancer modular elements.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2545910      PMCID: PMC250909          DOI: 10.1128/JVI.63.8.3353-3361.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  The role of MuLV receptors on T-lymphoma cells in lymphoma cell proliferation.

Authors:  M S McGrath; E Pillemer; D Kooistra; I L Weissman
Journal:  Contemp Top Immunobiol       Date:  1980

Review 2.  Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses.

Authors:  N C Jones; P W Rigby; E B Ziff
Journal:  Genes Dev       Date:  1988-03       Impact factor: 11.361

3.  Adenovirus DNA replication in vitro: identification of a host factor that stimulates synthesis of the preterminal protein-dCMP complex.

Authors:  K Nagata; R A Guggenheimer; T Enomoto; J H Lichy; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

4.  Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus.

Authors:  L A Laimins; G Khoury; C Gorman; B Howard; P Gruss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

Review 5.  Enhancer elements.

Authors:  G Khoury; P Gruss
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

6.  Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus.

Authors:  L A Laimins; P Gruss; R Pozzatti; G Khoury
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

7.  Determination of the leukaemogenicity of a murine retrovirus by sequences within the long terminal repeat.

Authors:  J Lenz; D Celander; R L Crowther; R Patarca; D W Perkins; W A Haseltine
Journal:  Nature       Date:  1984 Mar 29-Apr 4       Impact factor: 49.962

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  Thymotropism of murine leukemia virus is conferred by its long terminal repeat.

Authors:  L DesGroseillers; E Rassart; P Jolicoeur
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

10.  Expression and regulation of Escherichia coli lacZ gene fusions in mammalian cells.

Authors:  C V Hall; P E Jacob; G M Ringold; F Lee
Journal:  J Mol Appl Genet       Date:  1983
View more
  13 in total

1.  Differential DNA binding of nuclear proteins to a long terminal repeat region of the MCF13 and Akv murine leukemia viruses.

Authors:  F K Yoshimura; J Tupper; K Diem
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

2.  Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.

Authors:  J C Tupper; H Chen; E F Hays; G C Bristol; F K Yoshimura
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  In vitro transfection of fresh thymocytes and T cells shows subset-specific expression of viral promoters.

Authors:  T J Novak; F K Yoshimura; E V Rothenberg
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

4.  Analysis of enhancer function of the HS-40 core sequence of the human alpha-globin cluster.

Authors:  H Chen; C H Lowrey; G Stamatoyannopoulos
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

5.  Sequence analysis of porcine endogenous retrovirus long terminal repeats and identification of transcriptional regulatory regions.

Authors:  Carolyn A Wilson; Sabahat Laeeq; Armin Ritzhaupt; Winston Colon-Moran; Fayth K Yoshimura
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 6.  Amplified and tissue-directed expression of retroviral vectors using ping-pong techniques.

Authors:  M E Hoatlin; S L Kozak; C Spiro; D Kabat
Journal:  J Mol Med (Berl)       Date:  1995-03       Impact factor: 4.599

7.  A protein-binding site with dyad symmetry in the long terminal repeat of the MCF13 murine leukemia virus that contributes to transcriptional activity in T lymphocytes.

Authors:  F K Yoshimura; K Diem; H Chen; J Tupper
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Identification of a region of a murine leukemia virus long terminal repeat with novel transcriptional regulatory activities.

Authors:  H Chen; F K Yoshimura
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

9.  Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.

Authors:  S C Lawrenz-Smith; A C Massey; D J Innes; C Y Thomas
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Members of the GATA family of transcription factors bind to the U3 region of Cas-Br-E and graffi retroviruses and transactivate their expression.

Authors:  C Barat; E Rassart
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.